145 related articles for article (PubMed ID: 9881952)
1. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies.
Iizuka J; Katagiri Y; Tada N; Murakami M; Ikeda T; Sato M; Hirokawa K; Okada S; Hatano M; Tokuhisa T; Uede T
Lab Invest; 1998 Dec; 78(12):1523-33. PubMed ID: 9881952
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between osteopontin expression and autoimmune disease--analysis of osteopontin expressed in transgenic mice].
Iizuka J
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):487-95. PubMed ID: 9846278
[TBL] [Abstract][Full Text] [Related]
3. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
4. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
[TBL] [Abstract][Full Text] [Related]
5. T cell autoimmunity in Ig transgenic mice.
Shinde S; Gee R; Santulli-Marotto S; Bockenstedt LK; Clarke SH; Mamula MJ
J Immunol; 1999 Jun; 162(12):7519-24. PubMed ID: 10358207
[TBL] [Abstract][Full Text] [Related]
6. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.
Chan O; Shlomchik MJ
J Immunol; 1998 Jan; 160(1):51-9. PubMed ID: 9551955
[TBL] [Abstract][Full Text] [Related]
7. The roles of soluble osteopontin using osteopontin-transgenic mice in vivo: proliferation of CD4+ T lymphocytes and the enhancement of cell-mediated immune responses.
Higuchi Y; Tamura Y; Uchida T; Matsuura K; Hijiya N; Yamamoto S
Pathobiology; 2004; 71(1):1-11. PubMed ID: 14555839
[TBL] [Abstract][Full Text] [Related]
8. [Studies on expression and function of Eta-1(early T lymphocyte activation-1) in autoimmune prone MRL/Mp-lpr/lpr mice].
Mori K
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):708-17. PubMed ID: 7525433
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin is proinflammatory in experimental autoimmune uveitis.
Hikita ST; Vistica BP; Jones HR; Keswani JR; Watson MM; Ericson VR; Ayoub GS; Gery I; Clegg DO
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4435-43. PubMed ID: 17003437
[TBL] [Abstract][Full Text] [Related]
10. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
[TBL] [Abstract][Full Text] [Related]
11. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
[TBL] [Abstract][Full Text] [Related]
13. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease.
Lampe MA; Patarca R; Iregui MV; Cantor H
J Immunol; 1991 Nov; 147(9):2902-6. PubMed ID: 1918998
[TBL] [Abstract][Full Text] [Related]
15. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
[TBL] [Abstract][Full Text] [Related]
16. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
[TBL] [Abstract][Full Text] [Related]
17. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
Fournel S; Muller S
Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
[TBL] [Abstract][Full Text] [Related]
18. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice].
Zhai ZF; Zhou CL; Zhong BY; Ao JH; Hao F
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):406-10. PubMed ID: 18581896
[TBL] [Abstract][Full Text] [Related]
19. Long term administration of cyclophosphamide in MRL/1 mice. I. The effects on the development of immunological abnormalities and lupus nephritis.
Shiraki M; Fujiwara M; Tomura S
Clin Exp Immunol; 1984 Feb; 55(2):333-9. PubMed ID: 6607792
[TBL] [Abstract][Full Text] [Related]
20. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
